clinic neurophysiolog studi aldos reductas inhibitor ponalrestat chronic symptomat diabet peripher neuropathi flux polyol enzym aldos reductas develop diabet neuropathi fifty-four diabet patient median age yr yr chronic neuropath symptom reductas inhibit mg ponalrestat ici group wk patient vibrat percept threshold vpt great toe thermal differ threshold tt degre dorsum foot trial signific chang symptom pain numb paresthesia ponalrestat placebo group improv vpt TT sever site posterior tibial nerv conduct veloc m/ baselin m/ wk NS placebo m/ NS mg ponalrestat m/ NS mg ponalrestat further studi intervent stage evolut neuropathi period 